Member Info for Time2Retire

A serious question……

Why are there some people here who are only intent on running a share down with lies and half truths.

And there are some people here who are only intent on ramping a share up with lies and half truths.

Both types of people do little damage, except muddy the water for the truthful posters. Which is their aim I guess

Presumably we are earning a bucket load of cash in Nigeria with oil at $120 a barrel

……or hired as Boris’ communications director

Ruling adding more value to the share once th3 suspension is lifted

Surely it is sensible compare with two years ago which is pre-Covid.

Last year was during tight lockdown when all we did was cook at home, hence our numbers were higher. So comparisons with that are not comparing apples with apples.

Or am I missing something

Jeff I hope the bull market isn’t coming to an end quite yet.

A bear market and inflation is not a good mixture.

Not sure what tomorrow will bring, good results seem to be followed by a share price drop.

So let’s hope the share price drops tomorrow

Always good to see a director buying shares.

Of those approved, 21 are from businesses based in China, while at least another three are manufactured there.

Only one British company has received approval from the Government’s Porton Down testing labs and is delivering lateral flow kits to the NHS from its UK manufacturing facility – SureScreen. The company this month said it was increasing its production in the UK. It makes 1m tests every day.

In December Neale Hanvey, an Alba Party MP, accused the Government of “pulling the plug on the UK diagnostics industry when additional capacity is so obviously required”.

Tim Peto, another Oxford medical academic who works with Porton Down and advises the Government on testing, said: “British companies are unhappy, and I don’t know what we can do about that. Are we really meant to spend more time on them than on others?”

Let’s try and get as good a test as we can out to people who need it,” he added.

“That takes skill and patience and many companies have achieved a great result, so companies who cannot deliver should stop complaining and try harder.”

Sir John said supplies were “now looking good”, attributing much of the disruption to the public ordering a surplus of tests in the run-up to Christmas, to ensure they could continue seeing friends and family.

Last week, 19m lateral flow tests were distributed to the public. Officials believe the supply chain woes which plagued the country over the festive period have begun to fade.

Sir John’s comments follow growing scrutiny over where the UK is sourcing its lateral flow kits from. The Health Secretary, Sajid Javid, has blamed the shortage on the fact that Britain is “competing in a global market”, according to the Conservative MP Sir Roger Gale.

The majority of the lateral flow tests distributed by the NHS are manufactured in China, including tests made by US company Innova which has signed contracts with the Government worth as much as £3.7bn.

Companies have to go through a rigorous assessment process to be allowed to deliver tests through the NHS. More than 140 tests have been submitted for that assessment, and only 46 have been approved, according to the latest figures on the Government website.

The senior Covid scientist Sir John Bell has warned British manufacturers to “stop complaining and try harder” to make working lateral flow tests, after they claimed widespread shortages were caused by undue reliance on China.

Sir John, Regius Professor of Medicine at Oxford University and one of the Government’s leading advisers on the pandemic, hit back at complaints that domestic suppliers have not been able to secure approval for their tests.

He said there had been “quite a lot of noise from British manufacturers of lateral flow antigen tests”.

“But British companies have been, with one exception, universally unsuccessful at making these tests,” Sir John added.

One British company, Mologic, last year claimed it had been “stonewalled” by ministers over its attempt to get its kit approved. Some firms have tried multiple times.

Sir John said the Porton Down validation lab “just fairly assesses all the products that come and with the exception of SureScreen, which did really well, the UK industry has actually done badly and everybody needs to think about that”.

Interesting article, even if it puts British industry in a bad light

https://www.telegraph.co.uk/business/2022/01/08/british-firms-must-try-harder-make-covid-tests-says-sir-john/

I guess we will have to wait til April and the full year results to see what the Covid bonus looks like.

Assuming there is a Covid bonus, it certainly seems to be going under the radar of a lot of people.

Although I am showing a moderate gain on my holding, I am happy to wait and see what April brings, so I believe in it.

One of the downsides of the filter chat is you don’t see the rubbish everyone else is talking about.

But I overall I am happy not seeing it.

Happy Christmas all

Sorry, predictive text. Good call Beza

Beta called it!

Great point about the directors………

Why?

Light trading?
Profit taking?
Market manipulation?
Supply chain problems?

What was in the half year results that stopped this share from rising? I thought the results were good, so what did I miss?

Because last year was so exceptional year with lockdowns and therefore people cooking more at home, it seems sensible to compare with two years ago. It would be like saying England are the best team in the world because they won 10-0 last night. Everything has to be put in context

On that basis we are moving the right direction, debt has been considerably reduced, revenue is up, profit is up. Overall steady performance.

This is a big week for Nick and Phil, as it will give the real indication if the ship is turning in the right way.

I am positive.